Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II-Medical School, Naples, Italy.
Adv Biol Regul. 2021 Jan;79:100779. doi: 10.1016/j.jbior.2020.100779. Epub 2020 Dec 29.
Amyotrophic lateral sclerosis 8 (ALS8) is one of a heterogeneous group of progressive neurodegenerative disorders characterized by the death of motor neurons. ALS8 is caused by mutations in VAPB, a protein that acts at multiple membrane contact sites between the endoplasmic reticulum (ER) and almost all other organelles and thus affects functions at diverse cellular locations. One prominent function mediated by VAPB at these sites is lipid exchange, and a recurrent phenotype observed in all models investigating knockout or knockdown of VAPs is a significant increase in the levels of phosphatidylinositol-4-phosphate (PI4P). Here we consider the relevance of this PI4P deregulation in the development of ALS8 that might represent a potential target for therapeutic intervention.
肌萎缩性侧索硬化症 8 型(ALS8)是一组异质性进行性神经退行性疾病中的一种,其特征是运动神经元死亡。ALS8 是由 VAPB 基因突变引起的,VAPB 是一种在内质网(ER)和几乎所有其他细胞器之间的多个膜接触点起作用的蛋白质,因此影响不同细胞位置的功能。VAPB 在这些位点介导的一个突出功能是脂质交换,在所有研究 VAP 敲除或敲低的模型中观察到的一个反复出现的表型是磷脂酰肌醇-4-磷酸(PI4P)水平的显著增加。在这里,我们考虑这种 PI4P 失调在 ALS8 发展中的相关性,这可能代表治疗干预的潜在靶点。